Clinical Trial Site

Auckland 2025

2 studies enrolling now · 3 studies all time

What they study most

Genetic Disease, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Kidney Diseases, Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Transthyretin Amyloidosis With Cardiomyopathy, Urologic Diseases

Studies at this site

• TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Recruiting now
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 — Completed